Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weisman

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Surgery|November 1, 1994
A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerK T Robbins, D Vicario, S Seagren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
American Journal of Preventive Medicine|October 20, 2012
Influencing Taft-Hartley Funds to provide tobacco cessation benefitsSusan R Weisman, Deborah Hennrikus, Kelvin Choi, et al.
Dalton Transactions (Cambridge, England : 2003)|May 8, 2010
A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applicationsDannon J Stigers, Riccardo Ferdani, Gary R Weisman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formationG Los, f A Blommaert, R Barton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.
Dalton Transactions (Cambridge, England : 2003)|October 29, 2004
Inside or outside a ligand cleft? Synthetic, structural, and kinetic inertness studies of zinc, cadmium, and mercury complexes of cross-bridged cyclam and cyclenWeijun Niu, Edward H Wong, Gary R Weisman, et al.
Journal of Medicinal Chemistry|January 11, 2002
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligandsXiankai Sun, Melinda Wuest, Gary R Weisman, et al.
Journal of Medicinal Chemistry|April 27, 2007
Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agentsJennifer E Sprague, Yijie Peng, Ashley L Fiamengo, et al.
Dalton Transactions (Cambridge, England : 2003)|December 16, 2011
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsRiccardo Ferdani, Dannon J Stigers, Ashley L Fiamengo, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Surgery|November 1, 1994
A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerK T Robbins, D Vicario, S Seagren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
American Journal of Preventive Medicine|October 20, 2012
Influencing Taft-Hartley Funds to provide tobacco cessation benefitsSusan R Weisman, Deborah Hennrikus, Kelvin Choi, et al.
Dalton Transactions (Cambridge, England : 2003)|May 8, 2010
A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applicationsDannon J Stigers, Riccardo Ferdani, Gary R Weisman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formationG Los, f A Blommaert, R Barton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.
Dalton Transactions (Cambridge, England : 2003)|October 29, 2004
Inside or outside a ligand cleft? Synthetic, structural, and kinetic inertness studies of zinc, cadmium, and mercury complexes of cross-bridged cyclam and cyclenWeijun Niu, Edward H Wong, Gary R Weisman, et al.
Journal of Medicinal Chemistry|January 11, 2002
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligandsXiankai Sun, Melinda Wuest, Gary R Weisman, et al.
Journal of Medicinal Chemistry|April 27, 2007
Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agentsJennifer E Sprague, Yijie Peng, Ashley L Fiamengo, et al.
Dalton Transactions (Cambridge, England : 2003)|December 16, 2011
Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsRiccardo Ferdani, Dannon J Stigers, Ashley L Fiamengo, et al.
Pageof 10